Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease (2020)
Fonte: Biomedicine & Pharmacotherapy. Unidade: FMRP
Assuntos: PRÓPOLIS, COVID-19, ANTIVIRAIS, ANTI-INFLAMATÓRIOS, SISTEMA IMUNE, PRODUTOS NATURAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERRETTA, Andresa Aparecida et al. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease. Biomedicine & Pharmacotherapy, v. 131, p. 1-16, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2020.110622. Acesso em: 04 set. 2024.APA
Berretta, A. A., Silveira, M. A. D., Cóndor Capcha, J. M., & De Jong, D. (2020). Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease. Biomedicine & Pharmacotherapy, 131, 1-16. doi:10.1016/j.biopha.2020.110622NLM
Berretta AA, Silveira MAD, Cóndor Capcha JM, De Jong D. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease [Internet]. Biomedicine & Pharmacotherapy. 2020 ; 131 1-16.[citado 2024 set. 04 ] Available from: https://doi.org/10.1016/j.biopha.2020.110622Vancouver
Berretta AA, Silveira MAD, Cóndor Capcha JM, De Jong D. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease [Internet]. Biomedicine & Pharmacotherapy. 2020 ; 131 1-16.[citado 2024 set. 04 ] Available from: https://doi.org/10.1016/j.biopha.2020.110622